Bioluma

Status: Active Trial | Marker: no marker Title A phase II trial of nivolumab in combination with ipilimumab to evaluate efficacy and safety in relapsed lung cancer and to evaluate biomarkers predictive for response to immune checkpoint inhibition. Study Number...